First Time Loading...

Kazia Therapeutics Ltd
ASX:KZA

Watchlist Manager
Kazia Therapeutics Ltd Logo
Kazia Therapeutics Ltd
ASX:KZA
Watchlist
Price: 0.08 AUD Market Closed
Updated: May 2, 2024

Kazia Therapeutics Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kazia Therapeutics Ltd
Net Income (Common) Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Kazia Therapeutics Ltd
ASX:KZA
Net Income (Common)
-AU$20.5m
CAGR 3-Years
-18%
CAGR 5-Years
-28%
CAGR 10-Years
-39%
Immutep Ltd
ASX:IMM
Net Income (Common)
-AU$40.5m
CAGR 3-Years
-14%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Mesoblast Ltd
ASX:MSB
Net Income (Common)
-$73.1m
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Net Income (Common)
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
7%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Net Income (Common)
AU$30.2m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Net Income (Common)
AU$5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kazia Therapeutics Ltd's Net Income (Common)?
Net Income (Common)
-20.5m AUD

Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's Net Income (Common) amounts to -20.5m AUD.

What is Kazia Therapeutics Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-39%

Over the last year, the Net Income (Common) growth was 18%. The average annual Net Income (Common) growth rates for Kazia Therapeutics Ltd have been -18% over the past three years , -28% over the past five years , and -39% over the past ten years .